Cancer Comeback Rattles Tennis Icon

A 70-year-old tennis legend is now facing ovarian cancer for at least the third time—and she is turning that private nightmare into a public warning about how modern genetics can save lives.

Story Snapshot

Chris Evert says new CT and PET scans show her ovarian cancer has returned yet again.
She has already had surgery and plans to start chemotherapy in the coming weeks.^[1]
This battle follows earlier stage 1 ovarian cancer diagnoses linked to a BRCA1 gene mutation.^[9]
Media outlets frame her story as tragedy, but the deeper lesson is about early testing and truthful reporting.^[13]

A champion steps away from Wimbledon to fight for her life

Chris Evert told fans she will not be at Wimbledon this year because her ovarian cancer has returned.^[1] She shared that CT and PET scans over the weekend showed new disease, and she moved straight into surgery as the first step in treatment.^[1] She explained that chemotherapy is scheduled in the coming weeks and that she will step back from commentary and other work to focus on her health. For a woman who rarely skipped a big match, this is a serious pause.

Her announcement did not come through a formal press conference. It came through a short, direct statement on Instagram and the social platform X, where she has been open about her health for years.^[2] That choice matters. When a major figure uses her own voice, it cuts through spin and shows ownership of the story. In a media world that often hunts for drama, she chose clarity: this is a recurrence, it is serious, and it demands her full attention.^[1]

The long shadow of a BRCA1 mutation and a family tragedy

Evert’s current crisis did not start in 2026. It began with her sister Jeanne, who died of ovarian cancer in 2020 at age 62.^[5] Genetic testing later showed Jeanne carried a variant in the BRCA1 gene tied to higher cancer risk.^[4] That finding led doctors to test Chris’s blood. Her own test confirmed the same BRCA1 variant, which pushed her to undergo a preventive hysterectomy that unexpectedly uncovered stage 1 ovarian cancer in her fallopian tube.^[4]^[9]

Doctors told her that early surgery had removed all visible cancer and that chemotherapy gave her a better than 90 percent chance the disease would not return.^[4] She went through six rounds of treatment and shared that story to warn other women about quiet genetic risks.^[9] Even with that early win, about a year later another scan found a new cancerous mass, again at stage one.^[6] She endured surgery and treatment a second time, then celebrated being cancer-free in July 2024.^[2]^[6] Now, that relief has been cut short by yet another recurrence.

Why BRCA-linked cancers keep coming back

Her repeat battles line up with what researchers now see in many cancers driven by BRCA1 and BRCA2 mutations.^[13] These genes normally help repair damaged DNA. When they are altered, cancer risk jumps, especially for breast and ovarian cancer.^[17] Strong drugs and radiation aim to damage tumor DNA so the cells die. But in some BRCA-linked tumors, the cancer adapts. Studies have found certain tumors start using a shorter, more stable form of BRCA2 messenger RNA that boosts DNA repair and helps them survive treatment.^[13]

Scientists at major centers have shown that, in roughly one quarter of matched primary and recurrent tumors, the pattern of genetic changes in cancer cells shifts over time.^[15] Some tumors change how they lose or keep certain gene copies as they progress, which can make them more resistant to drugs.^[15] This helps explain why a woman like Evert can do “everything right”—early detection, surgery, chemotherapy—and still face new disease. It is not a failure of willpower. It is the harsh reality of a clever enemy at the molecular level.

Media framing, common sense, and what the public should demand

The news cycle rushed to cover Evert’s latest announcement. Headlines on television and online leaned hard on words like “tragedy” and “heartbreaking,” especially on social video channels that chase clicks.^[1] That emotional angle may grab attention, but it can drown out the medical facts and the practical lessons: know your family history, ask about genetic testing, and push for early screening if you are at risk.^[9]^[13] Sensation sells; information saves lives. A serious society should favor the second.

Evert announces ovarian cancer has returned

Chris Evert has announced on X that her ovarian cancer has returned for a third time, a disclosure that has prompted an outpouring of support from the tennis community. She will miss Wimbledon as a result of the recurrence. Evert had…

— The Tennis News (@research4tennis) June 26, 2026

Some independent posts even mock her diagnosis by pointing out that she no longer has ovaries, ignoring that ovarian-type cancers can start in nearby tissue and still return after surgery.^[3]^[17] That kind of shallow reaction clashes with basic decency and with conservative values that respect courage, family, and truth. A woman who spent decades working, paying taxes, and inspiring millions is now using her own suffering to warn others. The least the public can do is meet that sacrifice with honest discussion, not cheap jokes.

What Evert’s fight means for patients, families, and fans

Evert’s story shows how a single genetic test can change a life. When her sister’s BRCA1 variant was reclassified as clearly harmful, doctors advised Chris to get tested quickly.^[8]^[9] That call likely saved her life by catching cancer at stage one, when cure rates are far higher than in later stages.^[4] Many families never get that warning because they do not know their history or cannot access testing. Her message has been simple: learn your risk and act before symptoms appear.^[9]

Her choice to skip Wimbledon and step away from work sends another quiet signal: health comes before career, even for legends.^[1] For older readers who still “power through” chest pain or odd symptoms, her decision is a wake-up call. You are not weaker because you step back and seek care. You are wiser. Watching a world-class competitor pause the game to fight for her life might be the push some people need to schedule that overdue scan or ask a doctor about genetics. That may be the most important match she ever wins.